Press Release

Final Benefits & Payment Rule a “Win for Patients”

WASHINGTON, D.C. (April 28, 2022) – The Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO Stephen J. Ubl released the following statement after the Centers for Medicare & Medicaid Services finalized the Notice of Benefit and Payment Parameters (NBPP) rule that includes policies to help lower out-of-pocket costs for patients:

“Today’s Biden Administration decision on standardized benefit designs is a win for patients by ensuring insurance works like it should. This will make a real difference in lowering costs at the pharmacy for patients who get their insurance from These types of reforms help build a better health care system for everyone.”

This website uses cookies and other tracking technologies to optimize performance, preferences, usage, and statistics. By clicking “Accept All”, you consent to store on your device the cookies and other tracking technologies that require consent. You can tailor or change your preferences by clicking “Manage My Cookies”. You can check our privacy policy for more information.